Table 7.
Summary of results
| Subclinical cortisol secreting AI | Non-functioning AI | |
|---|---|---|
| Baseline prevalence (range) | ||
| DM/IGT | 16.6-90% | 9-27% |
| HTN | 33-85% | 24-86% |
| Dyslipidaemia | 9-90% | 5-60% |
| Obesity/overweight | 25-80% | 27-63% |
| Number of patients who had surgery | Range 10-55 Mean 22 | Range 21-43 |
| Significant improvement in surgically treated group (P<0.05) | ||
| DM/IGT | More than half of the studies | None; significant worsening in one study |
| HTN | Most studies | None |
| Dyslipidemia | Few studies | None; significant worsening in one study |
| Obesity/overweight | more than one third of the studies | None |
| Significant improvement in conservatively managed group (P<0.05) | ||
| DM/IGT | None | None; significant worsening in one-quarter of the studies |
| HTN | None; significant worsening in one study | None |
| Dyslipidemia | None | None; significant worsening in half of the studies |
| Obesity/overweight | None | None |